Compare AU
Compare IUSG vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the iShares U.S. Treasury Bond (Aud Hedged) ETF (IUSG) and the BetaShares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
IUSG | DRUG | |
|---|---|---|
Popularity | N/A | Low |
Pearlers invested | 0 | 61 |
Median incremental investment | $0 | $920.50 |
Median investment frequency | N/A | Monthly |
Median total investment | $0 | $1,995.65 |
Average age group | N/A | 26 - 35 |
Key Summary
IUSG | DRUG | |
|---|---|---|
Strategy | IUSG.AX was created on 2023-09-19 by iShares. The fund's investment portfolio concentrates primarily on investment grade fixed income. The Fund aims to provide investors with the performance of the ICE U.S. Treasury Core Bond AUD Hedged Index | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | iShares $ Treasury Bond ETF AUD H Dist (100.00 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) |
Top 3 industries | Other (75.92 %) Communication Services (33.53 %) Health Care (23.94 %) | |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | |
Management fee | 0.26 % | 0.57 % |
Key Summary
IUSG | DRUG | |
|---|---|---|
Issuer | iShares | BetaShares |
Tracking index | ICE U.S. Treasury Core Bond Index - AUD - Benchmark TR Net Hedged | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.26 % | 0.57 % |
Price | $102.13 | $8.27 |
Size | $20.002 million | $195.730 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 0.67 % | 1.89 % |
Market | ASX | ASX |
First listed date | 21/09/2023 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
IUSG | DRUG | |
|---|---|---|
Popularity | N/A | Low |
Pearlers invested | 0 | 61 |
Median incremental investment | $0 | $920.50 |
Median investment frequency | N/A | Monthly |
Median total investment | $0 | $1,995.65 |
Average age group | N/A | 26 - 35 |
Pros and Cons
IUSG | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
IUSG | DRUG |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |